Locus coeruleus response to single-prolonged stress and early intervention with intranasal neuropeptide y

Journal of Neurochemistry

Volumn 135, Issue 5, 2015, Pages 975-986

  Sabban, Esther L ^a   Laukova, Marcela ^a,b   Alaluf, Lishay G ^a   Olsson, Emelie ^a,c   Serova, Lidia I ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b INSTITUTE OF EXPERIMENTAL ENDOCRINOLOGY   (Slovakia)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

corticotropin releasing hormone; glucocorticoid receptor; locus coeruleus; neuropeptide Y; post traumatic stress disorder; tyrosine hydroxylase

Indexed keywords

CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; NEUROPEPTIDE Y; NEUROPEPTIDE Y1 RECEPTOR; NEUROPEPTIDE Y2 RECEPTOR; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR; DOPAMINE BETA MONOOXYGENASE; MESSENGER RNA; NEUROPEPTIDE Y RECEPTOR; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN STEM INJURY; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFICACY; DRUG MECHANISM; EARLY INTERVENTION; GENE EXPRESSION; LOCUS CERULEUS; MALE; NEUROPROTECTION; NONHUMAN; POSTTRAUMATIC STRESS DISORDER; PRESYNAPTIC INHIBITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; SINGLE DRUG DOSE; TREATMENT RESPONSE; UPREGULATION; ADVERSE EFFECTS; ANIMAL; DISEASE MODEL; DRUG EFFECTS; EXERCISE; GENE EXPRESSION REGULATION; GENETICS; INTRANASAL DRUG ADMINISTRATION; MAZE TEST; METABOLISM; PATHOLOGY; PHYSIOLOGY; PROCEDURES; SPRAGUE DAWLEY RAT; STRESS DISORDERS, POST-TRAUMATIC;

ADMINISTRATION, INTRANASAL; ANIMALS; CORTICOTROPIN-RELEASING HORMONE; DISEASE MODELS, ANIMAL; DOPAMINE BETA-HYDROXYLASE; GENE EXPRESSION REGULATION; LOCUS COERULEUS; MALE; MAZE LEARNING; NEUROPEPTIDE Y; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; RECEPTORS, NEUROPEPTIDE Y; RESTRAINT, PHYSICAL; RNA, MESSENGER; STRESS DISORDERS, POST-TRAUMATIC; TYROSINE 3-MONOOXYGENASE;

EID: 84955236719     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.13347     Document Type: Article

References (76)

1. Armony J. L., Corbo V., Clément M. H., and, Brunet A., (2005) Amygdala response in patients with acute PTSD to masked and unmasked emotional facial expressions. Am. J. Psychiatry 162, 1961-1963.
2. Aston-Jones G., and, Cohen J. D., (2005) An integrative theory of locus coeruleus-norepinephrine function: adaptive gain and optimal performance. Annu. Rev. Neurosci. 28, 403-450.
3. Aston-Jones G., Rajkowski J., Kubiak P., Valentino R. J., and, Shipley M. T., (1996) Role of the locus coeruleus in emotional activation. Prog. Brain Res. 107, 379-402.
4. Baker D. G., West S. A., Nicholson W. E., Ekhator N. N., Kasckow J. W., Hill K. K., Bruce A. B., Orth D. N., and, Geracioti T. D., (1999) Serial CSF corticotropin-releasing hormone levels and adrenocortical activity in combat veterans with posttraumatic stress disorder. Am. J. Psychiatry 156, 585-588.
5. Bangasser D. A., Curtis A., Reyes B. A., Bethea T. T., Parastatidis I., Ischiropoulos H., Van Bockstaele E. J., and, Valentino R. J., (2010) Sex differences in corticotropin-releasing factor receptor signaling and trafficking: potential role in female vulnerability to stress-related psychopathology. Mol. Psychiatry 15, 877, 896-904.
6. Boscarino J. A., Erlich P. M., Hoffman S. N., Rukstalis M., and, Stewart W. F., (2011) Association of FKBP5, COMT and CHRNA5 polymorphisms with PTSD among outpatients at risk for PTSD. Psychiatry Res. 188, 173-174.
7. Brady L. S., (1994) Stress, antidepressant drugs, and the locus coeruleus. Brain Res. Bull. 35, 545-556.
8. Bremner J. D., Licinio J., Darnell A., Krystal J. H., Owens M. J., Southwick S. M., Nemeroff C. B., and, Charney D. S., (1997) Elevated CSF corticotropin-releasing factor concentrations in posttraumatic stress disorder. Am. J. Psychiatry 154, 624-629.
9. Charney D. S., (2004) Psychobiological mechanisms of resilience and vulnerability: implications for successful adaptation to extreme stress. Am. J. Psychiatry 161, 195-216.
10. Cohen H., Liu T., Kozlovsky N., Kaplan Z., Zohar J., and, Mathé A. A., (2012) The neuropeptide Y (NPY)-ergic system is associated with behavioral resilience to stress exposure in an animal model of post-traumatic stress disorder. Neuropsychopharmacology 37, 350-363.
11. Curtis A. L., Bello N. T., Connolly K. R., and, Valentino R. J., (2002) Corticotropin-releasing factor neurones of the central nucleus of the amygdala mediate locus coeruleus activation by cardiovascular stress. J. Neuroendocrinol. 14, 667-682.
12. Curtis A. L., Leiser S. C., Snyder K., and, Valentino R. J., (2012) Predator stress engages corticotropin-releasing factor and opioid systems to alter the operating mode of locus coeruleus norepinephrine neurons. Neuropharmacology 62, 1737-1745.
13. Eagle A. L., Knox D., Roberts M. M., Mulo K., Liberzon I., Galloway M. P., and, Perrine S. A., (2013) Single prolonged stress enhances hippocampal glucocorticoid receptor and phosphorylated protein kinase B levels. Neurosci. Res. 75, 130-137.
14. Eaton K., Sallee F. R., and, Sah R., (2007) Relevance of neuropeptide Y (NPY) in psychiatry. Curr. Top. Med. Chem. 7, 1645-1659.
15. Enman N. M., Sabban E. L., McGonigle P., and, Van Bockstaele E. J., (2015) Targeting the neuropeptide Y system in stress-related psychiatric disorders. Neurobiol. Stress 1, 33-43.
16. Finta E. P., Regenold J. T., and, Illes P., (1992) Depression by neuropeptide Y of noradrenergic inhibitory postsynaptic potentials of locus coeruleus neurones. Naunyn Schmiedebergs Arch. Pharmacol. 346, 472-474.
17. George S. A., Knox D., Curtis A. L., Aldridge J. W., Valentino R. J., and, Liberzon I., (2013) Altered locus coeruleus-norepinephrine function following single prolonged stress. Eur. J. Neurosci. 37, 901-909.
18. Geracioti T. D., Jr, Baker D. G., Ekhator N. N., et al,. (2001) CSF norepinephrine concentrations in posttraumatic stress disorder. Am. J. Psychiatry 158, 1227-1230.
19. Geracioti T. D., Baker D. G., Kasckow J. W., Strawn J. R., Jeffrey Mulchahey J., Dashevsky B. A., Horn P. S., and, Ekhator N. N., (2008) Effects of trauma-related audiovisual stimulation on cerebrospinal fluid norepinephrine and corticotropin-releasing hormone concentrations in post-traumatic stress disorder. Psychoneuroendocrinology 33, 416-424.
20. Hebert M. A., Serova L. I., and, Sabban E. L., (2005) Single and repeated immobilization stress differentially trigger induction and phosphorylation of several transcription factors and mitogen-activated protein kinases in the rat locus coeruleus. J. Neurochem. 95, 484-498.
21. Heilig M., (2004) The NPY system in stress, anxiety and depression. Neuropeptides 38, 213-224.
22. Heilig M., Koob G. F., Ekman R., and, Britton K. T., (1994) Corticotropin-releasing factor and neuropeptide Y: role in emotional integration. Trends Neurosci. 17, 80-85.
23. Illes P., Finta E. P., and, Nieber K., (1993) Neuropeptide Y potentiates via Y2-receptors the inhibitory effect of noradrenaline in rat locus coeruleus neurones. Naunyn Schmiedebergs Arch. Pharmacol. 348, 546-548.
24. Jedema H. P., Finlay J. M., Sved A. F., and, Grace A. A., (2001) Chronic cold exposure potentiates CRH-evoked increases in electrophysiologic activity of locus coeruleus neurons. Biol. Psychiatry 49, 351-359.
25. Jedema H. P., and, Grace A. A., (2004) Corticotropin-releasing hormone directly activates noradrenergic neurons of the locus ceruleus recording in vitro. J Neurosci. 24, 9703-9713.
26. Kalin N. H., Takahashi L. K., and, Chen F. L., (1994) Restraint stress increases corticotropin-releasing hormone mRNA content in the amygdala and paraventricular nucleus. Brain Res. 656, 182-186.
27. Kask A., Rägo L., and, Harro J., (1998) Anxiolytic-like effect of neuropeptide Y (NPY) and NPY13-36 microinjected into vicinity of locus coeruleus in rats. Brain Res. 788, 345-348.
28. Kask A., Harro J., von Hörsten S., Redrobe J. P., Dumont Y., and, Quirion R., (2002) The neurocircuitry and receptor subtypes mediating anxiolytic-like effects of neuropeptide Y. Neurosci. Biobehav. Rev. 26, 259-283.
29. Kohda K., Harada K., Kato K., Hoshino A., Motohashi J., Yamaji T., Morinobu S., Matsuoka N., and, Kato N., (2007) Glucocorticoid receptor activation is involved in producing abnormal phenotypes of single-prolonged stress rats: a putative post-traumatic stress disorder model. Neuroscience 148, 22-33.
30. Kvetnansky R., Sabban E. L., and, Palkovits M., (2009) Catecholaminergic systems in stress: structural and molecular genetic approaches. Physiol. Rev. 89, 535-606.
31. Laukova M., Alaluf L. G., Serova L. I., Arango V., and, Sabban E. L., (2014) Early intervention with intransala NPY prevents single prolonged stress-triggered impairments in hypothalamus and ventral hippocampus in male rats. Endocrinology 155, 3920-3933.
32. Lewis E. J., Tank A. W., Weiner N., and, Chikaraishi D. M., (1983) Regulation of tyrosine hydroxylase mRNA by glucocorticoid and cyclic AMP in a rat pheochromocytoma cell line. Isolation of a cDNA clone for tyrosine hydroxylase mRNA. J. Biol. Chem. 258, 14632-14637.
33. Li M., Han F., and, Shi Y., (2011) Expression of locus coeruleus mineralocorticoid receptor and glucocorticoid receptor in rats under single-prolonged stress. Neurol. Sci. 32, 625-631.
34. Liberzon I., Lõpez J. F., Flagel S. B., Vázquez D. M., and, Young E. A., (1999) Differential regulation of hippocampal glucocorticoid receptors mRNA and fast feedback: relevance to post-traumatic stress disorder. J. Neuroendocrinol. 11, 11-17.
35. Ma S., Mifflin S. W., Cunningham J. T., and, Morilak D. A., (2008) Chronic intermittent hypoxia sensitizes acute hypothalamic-pituitary-adrenal stress reactivity and Fos induction in the rat locus coeruleus in response to subsequent immobilization stress. Neuroscience 154, 1639-1647.
36. Makino S., Shibasaki T., Yamauchi N., Nishioka T., Mimoto T., Wakabayashi I., Gold P. W., and, Hashimoto K., (1999) Psychological stress increased corticotropin-releasing hormone mRNA and content in the central nucleus of the amygdala but not in the hypothalamic paraventricular nucleus in the rat. Brain Res. 850, 136-143.
37. Makino S., Smith M. A., and, Gold P. W., (2002) Regulatory role of glucocorticoids and glucocorticoid receptor mRNA levels on tyrosine hydroxylase gene expression in the locus coeruleus during repeated immobilization stress. Brain Res. 943, 216-223.
38. Mana M. J., and, Grace A. A., (1997) Chronic cold stress alters the basal and evoked electrophysiological activity of rat locus coeruleus neurons. Neuroscience 81, 1055-1064.
39. McMahon A., and, Sabban E. L., (1992) Regulation of expression of dopamine beta-hydroxylase in PC12 cells by glucocorticoids and cyclic AMP analogues. J. Neurochem. 59, 2040-2047.
40. Melia K. R., and, Duman R. S., (1991) Involvement of corticotropin-releasing factor in chronic stress regulation of the brain noradrenergic system. Proc. Natl Acad. Sci. USA 88, 8382-8386.
41. Morgan C. A., 3rd, Rasmusson A. M., Wang S., Hoyt G., Hauger R. L., and, Hazlett G., (2002) Neuropeptide-Y, cortisol, and subjective distress in humans exposed to acute stress: replication and extension of previous report. Biol. Psychiatry 52, 136-142.
42. Morilak D. A., Barrera G., Echevarria D. J., Garcia A. S., Hernandez A., Ma S., and, Petre C. O., (2005) Role of brain norepinephrine in the behavioral response to stress. Prog. Neuropsychopharmacol. Biol. Psychiatry 29, 1214-1224.
43. Nicolaides N. C., Charmandari E., Chrousos G. P., and, Kino T., (2014) Recent advances in the molecular mechanisms determining tissue sensitivity to glucocorticoids: novel mutations, circadian rhythm and ligand-induced repression of the human glucocorticoid receptor. BMC Endocr. Disord. 14, 71.
44. O'Donnell T., Hegadoren K. M., and, Coupland N. C., (2004) Noradrenergic mechanisms in the pathophysiology of post-traumatic stress disorder. Neuropsychobiology 50, 273-283.
45. Paxinos G., and, Watson C., (1998) The Rat Brain in Stereotaxic Coordinates, Academic Press Inc, San Diego.
46. Pervanidou P., and, Chrousos G. P., (2010) Neuroendocrinology of post-traumatic stress disorder. Prog. Brain Res. 182, 149-160.
47. Protopopescu X., Pan H., Tuescher O., et al,. (2005) Differential time courses and specificity of amygdala activity in posttraumatic stress disorder subjects and normal control subjects. Biol. Psychiatry 57, 464-473.
48. Rani C. S., Elango N., Wang S. S., Kobayashi K., and, Strong R., (2009) Identification of an activator protein-1-like sequence as the glucocorticoid response element in the rat tyrosine hydroxylase gene. Mol. Pharmacol. 75, 589-598.
49. Rasmusson A. M., Hauger R. L., Morgan C. A., Bremner J. D., Charney D. S., and, Southwick S. M., (2000) Low baseline and yohimbine-stimulated plasma neuropeptide Y (NPY) levels in combat-related PTSD. Biol. Psychiatry 47, 526-539.
50. Sabban E. L., and, Kvetnansky R., (2001) Stress-triggered activation of gene expression in catecholaminergic systems: dynamics of transcriptional events. Trends Neurosci. 24, 91-98.
51. Sabban E. L., Serova L. I., Alaluf L. G., Laukova M., and, Peddu C., (2014) Comparative effects of intranasal neuropeptide Y and HS014 in preventing anxiety and depressive-like behavior elicited by single prolonged stress. Behav. Brain Res. doi: 10.1016/j.bbr.2014.12.038. [Epub ahead of print].
52. Sah R., and, Geracioti T. D., (2013) Neuropeptide Y and posttraumatic stress disorder. Mol. Psychiatry 18, 646-655.
53. Sah R., Ekhator N. N., Strawn J. R., Sallee F. R., Baker D. G., Horn P. S., and, Geracioti T. D., (2009) Low cerebrospinal fluid neuropeptide Y concentrations in posttraumatic stress disorder. Biol. Psychiatry 66, 705-707.
54. Sah R., Ekhator N. N., Jefferson-Wilson L., Horn P. S., and, Geracioti T. D., (2014) Cerebrospinal fluid neuropeptide Y in combat veterans with and without posttraumatic stress disorder. Psychoneuroendocrinology 40, 277-283.
55. Sajdyk T. J., Johnson P. L., Leitermann R. J., Fitz S. D., Dietrich A., Morin M., Gehlert D. R., Urban J. H., and, Shekhar A., (2008) Neuropeptide Y in the amygdala induces long-term resilience to stress-induced reductions in social responses but not hypothalamic-adrenal-pituitary axis activity or hyperthermia. J. Neurosci. 28, 893-903.
56. Sara S. J., (2009) The locus coeruleus and noradrenergic modulation of cognition. Nat. Rev. Neurosci. 10, 211-223.
57. Schulz C., and, Lehnert H., (1996) Activation of noradrenergic neurons in the locus coeruleus by corticotropin-releasing factor. A microdialysis study. Neuroendocrinology 63, 454-458.
58. Serova L. I., Nankova B. B., Feng Z., Hong J. S., Hutt M., and, Sabban E. L., (1999) Heightened transcription for enzymes involved in norepinephrine biosynthesis in the rat locus coeruleus by immobilization stress. Biol. Psychiatry 45, 853-862.
59. Serova L. I., Laukova M., Alaluf L. G., and, Sabban E. L., (2013a) Intranasal infusion of melanocortin receptor four (MC4R) antagonist to rats ameliorates development of depression and anxiety related symptoms induced by single prolonged stress. Behav. Brain Res. 250, 139-147.
60. Serova L. I., Tillinger A., Alaluf L. G., Laukova M., Keegan K., and, Sabban E. L., (2013b) Single intranasal neuropeptide Y infusion attenuates development of PTSD-like symptoms to traumatic stress in rats. Neuroscience 236, 298-312.
61. Serova L. I., Laukova M., Alaluf L. G., Pucillo L., and, Sabban E. L., (2014) Intranasal neuropeptide Y reverses anxiety and depressive-like behavior impaired by single prolonged stress PTSD model. Eur. Neuropsychopharmacol. 24, 142-147.
62. Sheriff S., Dautzenberg F. M., Mulchahey J. J., Pisarska M., Hauger R. L., Chance W. T., Balasubramaniam A., and, Kasckow J. W., (2001) Interaction of neuropeptide Y and corticotropin-releasing factor signaling pathways in AR-5 amygdalar cells. Peptides 22, 2083-2089.
63. Smith M. A., Brady L. S., Glowa J., Gold P. W., and, Herkenham M., (1991) Effects of stress and adrenalectomy on tyrosine hydroxylase mRNA levels in the locus ceruleus by in situ hybridization. Brain Res. 544, 26-32.
64. Southwick S. M., Bremner J. D., Rasmusson A., Morgan C. A., Arnsten A., and, Charney D. S., (1999) Role of norepinephrine in the pathophysiology and treatment of posttraumatic stress disorder. Biol. Psychiatry 46, 1192-1204.
65. Strawn J. R., and, Geracioti T. D., (2008) Noradrenergic dysfunction and the psychopharmacology of posttraumatic stress disorder. Depress. Anxiety 25, 260-271.
66. Sun B., Chen X., Xu L., Sterling C., and, Tank A. W., (2004) Chronic nicotine treatment leads to induction of tyrosine hydroxylase in locus ceruleus neurons: the role of transcriptional activation. Mol. Pharmacol. 66, 1011-1021.
67. Taneja M., Salim S., Saha K., Happe H. K., Qutna N., Petty F., Bylund D. B., and, Eikenburg D. C., (2011) Differential effects of inescapable stress on locus coeruleus GRK3, alpha2-adrenoceptor and CRF1 receptor levels in learned helpless and non-helpless rats: a potential link to stress resilience. Behav. Brain Res. 221, 25-33.
68. Tank A. W., Xu L., Chen X., Radcliffe P., and, Sterling C. R., (2008) Post-transcriptional regulation of tyrosine hydroxylase expression in adrenal medulla and brain. Ann. N. Y. Acad. Sci. 1148, 238-248.
69. Tekin I., Roskoski R., Carkaci-Salli N., and, Vrana K. E., (2014) Complex molecular regulation of tyrosine hydroxylase. J. Neural. Transm. 121, 1451-1481.
70. Thorsell A., (2010) Brain neuropeptide Y and corticotropin-releasing hormone in mediating stress and anxiety. Exp. Biol. Med. (Maywood) 235, 1163-1167.
71. Valentino R. J., and, Van Bockstaele E., (2008) Convergent regulation of locus coeruleus activity as an adaptive response to stress. Eur. J. Pharmacol. 583, 194-203.
72. Valentino R. J., Van Bockstaele E., and, Bangasser D., (2013) Sex-specific cell signaling: the corticotropin-releasing factor receptor model. Trends Pharmacol. Sci. 34, 437-444.
73. Van Bockstaele E. J., Colago E. E., and, Valentino R. J., (1998) Amygdaloid corticotropin-releasing factor targets locus coeruleus dendrites: substrate for the co-ordination of emotional and cognitive limbs of the stress response. J. Neuroendocrinol. 10, 743-757.
74. Wang S. S., Yan X. B., Hofman M. A., Swaab D. F., and, Zhou J. N., (2010) Increased expression level of corticotropin-releasing hormone in the amygdala and in the hypothalamus in rats exposed to chronic unpredictable mild stress. Neurosci. Bull. 26, 297-303.
75. Wu G., Feder A., Wegener G., Bailey C., Saxena S., Charney D., and, Mathé A. A., (2011) Central functions of neuropeptide Y in mood and anxiety disorders. Expert Opin. Ther. Targets 15, 1317-1331.
76. Yehuda R., Brand S., and, Yang R. K., (2006) Plasma neuropeptide Y concentrations in combat exposed veterans: relationship to trauma exposure, recovery from PTSD, and coping. Biol. Psychiatry 59, 660-663.